Chronic Myelomonocytic Leukemia Recruiting Phase 2 Trials for Tacrolimus (DB00864)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02566304Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment
NCT01760655Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesTreatment
NCT01773395GVAX vs. Placebo for MDS/AML After Allo HSCTTreatment
NCT01384513A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesTreatment
NCT03734601Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell TransplantationTreatment